ArticleContemporary clinical trials communications2024

Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.

Jeffrey D Jenks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.